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Introduction 
The pterin 4a-carbinolamine dehydratase (P4aCD) is 
an enzyme that catalyzed the dehydration of the 4a-
carbinolamine, the tetrahydrobiopterin derived inter-
mediate product by phenylalanine hydroxylase (PAH) 
catalyzed reaction, to form q-dihydropterin. The de-
hydratase is of special interest because it is proposed, 
that a new variant form of hyperphenylalaninemia 
(primapterinuria) can be caused by absence of this 
enzyme. Recently, Curtius et al. have described pa-
tients with characteristic excretion of 7-substituted 
pterins (primapterin, anapterin and 6-oxo-prima-
pterin) in urine (1). New data on the formation of 
primapterin during PAH catalyzed reaction in the 
absence of dehydratase and the proposed detailed 
chemical mechanism for 7-substituted pterin forma-
tion suggest the evidence, that the enzyme P4aCD 
can be deficient in these patients (2). In order to study 
the novel aspects of PAH catalyzed reaction and the 
mechanism of 7-substituted pterin formation, we de-
scribed purification procedure for dehydratase from 
human liver, partial characterization of this enzyme 
and comparison with P4aCD from rat liver. 
Materials 
Phenyl Sepharose CL-4B, chromatofocussing kit, Se-
pacryl S-200 HR were purchased from Pharmacia. 
Hydroxylapatite Biogel HT was from Bio-Rad. The 
human livers were obtained from kidney transplan-
tation donors and used immediately. 
Methods 
Purification P4aCD 
All procedures were performed at 4 °C, unless oth-
erwise stated. 
200 g liver was homogenized in buffer A (0.03 M Tris/ 
HCl, pH 7.4, 0.02 m L-phenylalanine, 0.75 M KCl). 
The homogenate was centrifuged at 105 g for 60 min 
and supernatant (liver extract) was incubated at 25 °C 
for 10 min (3). The activated extract was applied to 
phenyl Sepharose column (5.10 χ 10 cm) which was 
equilibrated with buffer A containing 0.1% Tween 80 
(flow rate was 800 ml/h). The column was washed 
with 250 ml buffer A and then with 1000 ml buffer 
Β (0.03 m Tris/HCl, pH 7.4, 0.01 m L-phenylalanine, 
0.15 M KCl and 4.8% dimethylformamide). The first 
2.5 bed volumes of the dimethylformamide containing 
wash were collected and solid (NH4)2S04 was added 
to obtain 80% saturation. The precipitate was col-
lected by centrifugation, dissolved in a small volume 
of buffer C (5 mM potasium phosphate buffer, pH 
6.8, 0.1 M KCl) and dialyzed against the same buffer. 
The dialyzed sample was applied to a Biogel HT 
column (3.2 χ 18cm), washed with 250 ml buffer C 
and eluted with 20 mM potassium phosphate buffer, 
pH 6.8, 0.1 M KCl. The fractions containing enzyme 
activity were precipitated with 60% (NH4)2S04. The 
precipitate was dissolved in a small volume of 0.025 M 
imidazol buffer, pH 7.4, and dialyzed against the same 
buffer. The sample was separated on a chromatofo-
cussing column (1.0 χ 30 cm) with pH gradient from 
7.4 to 5.0 according instructions from Pharmacia. 
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Table 1. Purification of pterin 4a-carbinolamine dehydratase from human liver. 
Purification step Total Activity 
(units3) 
Total Protein 
(mg) 
Specific Activity 
(units/mg) 
Purification 
(-fold) 
Yield 
(%) 
Crude extract 2336 14500 0.16 1 100 
Phenyl Sepharose/80% (NH4)2S04 1817 790 2.3 14 78 
Biogel HT pool 1525 82 18.6 116 65 
Chromatofocussing pool 1060.5 10.1 105.0 656 45 
Gel filtration pool 940.5 4.5 158.0 990 30 
a 1 unit is defined as 1 μηιοί tyrosine formed per 30 min 
P4aCD active fractions were pooled, concentrated to 
1.5 ml (Amicon Centriprep-10) and separated on a 
Sephacryl S-200 HR column (1.6 χ 100 cm) with 
buffer C at flow rate of 25 ml/h. The final dehydratase 
pool was concentrated and stored at — 80 °C. 
The dehydratase from rat liver was purified according 
to the method of Parniak (4), followed by two further 
purification steps: column chromatofocussing and gel 
filtration. Dehydratase-free PAH was obtained ac-
cording to Shiman (3). The activity of enzymes were 
assayed fluorimetrically (5). 
Results 
The purification of P4aCD was 990-fold as deter-
mined by the enzyme assay, based on stimulation of 
PAH activity (5), and represents a 30% yield (Table 
1). Absorption chromatography and column chro-
matofocussing were the main purification steps in our 
procedure (Table 1). The isoelectric point for human 
liver enzyme upon chromatofocussing was estimated 
as 5.25. The last purification step resulted in a single 
symmetrical peak of activity, corresponding to an Mr 
of 45 000. SDS/polyacrylamide-gel electrophoresis of 
the enzyme activity peak eluted from the size column 
demonstrated the presence of a single 11 000-Mr com-
ponent. The enzymes were separated by SDS gel elec-
trophoresis and after entrapment of liberated phos-
phate the gel was stained with methyl green. Both 
enzymes (from rat and from human liver) showed a 
bright green colored band specifically for phospho-
proteins (data not shown). The amino acid composi-
tion of purified enzymes was also determined and 
high level of glutamic acid, aspartic acid, alanine and 
leucine were detected (Table 2). 
Discussion 
We have described the purification of P4aCD from 
human liver by 990-fold with a recovery of 30%. This 
is a simple purification protocol utilizing a four col-
umn procedure that includes a phenyl Sepharose step, 
Table 2. Comparison of amino acid composition of rat and 
human pterin 4a-carbinolamine dehydratase. 
Amino acid Residues/mol of subunit P4aCD 
Human liver Rat liver Rat liver" 
Lysine 5.4 4.7 6.1 
Histidine 4.2 4.6 5.4 
Arginine 5.9 5.9 7.6 
Cysteine & 1.2 1.1 1.4 
Cystic acid 1.2 1.1 1.4 
Aspartic acid 9.9 9.9 12.1 
Threonine 3.9 3.9 4.4 
Serine 3.7 4.3 5.8 
Glutamine acid 12.9 12.6 14.8 
Proline 3.1 2.7 3.3 
Glycine 5.7 6.3 6.6 
Alanine 9.8 9.3 10.8 
Valine 5.4 5.2 6.6 
Methionine 0.9 0.9 1.9 
Isoleucine 3.6 3.8 4.7 
Leucine 9.3 9.1 11.4 
Tyrosine 0.8 0.8 1.5 
Phenylalanine 6.6 6.7 7.6 
Tryptophan ND N D 1.0 
Mr 11 000 11000 12900 
" Values from Huang et al. (5) 
absorption chromatography, column chromatofo-
cussing and gel filtration chromatography. Approxi-
mately 80% of the dehydratase activity was bound 
and eluted from phenyl Sepharose column under the 
conditions employed (use of 0.75 M KCl in homoge-
nization buffer). This step in the purification was 
based on the previous finding that rat liver P4aCD 
bound strongly to hydrophobic support in the buffer 
with high ionic strength (0.5 M KCl) and could be 
eluted by decreasing it (4). Remarkably, the PAH 
bind strongly to phenyl Sepharose by substrate in-
duced interaction (3). Our purification procedure has 
the additional advantage that both enzymes involved 
in phenylalanine hydroxylation can be conveniently 
obtained from the same human liver sample, similar 
as described for rat enzymes (4). 
It is likely that the native human liver dehydratase 
(Mr 45 000) consist of four subunits with equal Mr 
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of 11 000, as it has been shown for rat liver enzyme 
(5). The acidic properties of P4aCD (pi = 5.25) are 
confirmed by estimated high level of dicarbon amino 
acid after amino acid analysis (Table 2). Physicochem-
ical studies suggest that the enzyme from human liver 
is very similar to that from rat liver: Mr, subunit 
number, pi, amino acid composition, both enzyme 
are might be phosphoproteins. However, further stud-
ies are required to start the characterization of pri-
mapterinuric patients by means of biochemical, im-
munological and molecular-biological methods. 
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